Brindisi, M.; Butini, S.; Franceschini, S.; Brogi, S.; Trotta, F.; Ros, S.; Cagnotto, A.; Salmona, M.; Casagni, M.; Andreassi, M.; Saponara, S.; Gorelli, B.; Weikop, P.; Mikkelsen, J. D.; Scheel-Kruger, J.; Sandager-Nielsen, K.; Novellino, E.; Campiani, G.; Gemma, S. Targeting Dopamine D3 and Serotonin 5-HT1A and 5-HT2A Receptors for Developing Effective Antipsychotics: Synthesis, Biological Characterization, and Behavioral Studies J. Med. Chem. 2014, 57, 9578-9597 10.1021/jm501119j
Fiorino, F.; Severino, B.; Magli, E.; Ciano, A.; Caliendo, G.; Santagada, V.; Frecentese, F.; Perissutti, E. 5-HT1A Receptor: An Old Target as a New Attractive Tool in Drug Discovery from Central Nervous System to Cancer J. Med. Chem. 2014, 57, 4407-4426 10.1021/jm400533t
Lian, P.; Li, L.; Geng, C.; Zhen, X.; Fu, W. Higher-Affinity Agonists of 5-HT1AR Discovered through Tuning the Binding-Site Flexibility J. Chem. Inf. Model. 2015, 55, 1616-1627 10.1021/acs.jcim.5b00164
Luo, M.; Wang, X. S.; Roth, B. L.; Golbraikh, A.; Tropsha, A. Application of Quantitative Structure-Activity Relationship Models of 5-HT1A Receptor Binding to Virtual Screening Identifies Novel and Potent 5-HT1A Ligands J. Chem. Inf. Model. 2014, 54, 634-647 10.1021/ci400460q
Forster, E. A.; Cliffe, I. A.; Bill, D. J.; Dover, G. M.; Jones, D.; Reilly, Y.; Fletcher, A. A Pharmacological Profile of the Selective Silent 5-HT1A Receptor Antagonist, WAY-100635 Eur. J. Pharmacol. 1995, 281, 81-88 10.1016/0014-2999(95)00234-C
Chemel, B. R.; Roth, B. L.; Armbruster, B.; Watts, V. J.; Nichols, D. E. WAY-100635 is a Potent Dopamine D4 Receptor Agonist Psychopharmacology (Berl) 2006, 188, 244-251 10.1007/s00213-006-0490-4
Marona-Lewicka, D.; Nichols, D. E. WAY 100635 Produces Discriminative Stimulus Effects in Rats Mediated by Dopamine D(4) Receptor Activation Behav. Pharmacol. 2009, 20, 114-118 10.1097/FBP.0b013e3283242f1a
Al Hussainy, R.; Verbeek, J.; van der Born, D.; Booij, J.; Herscheid, J. K. Design, Synthesis and In Vitro Evaluation of Bridgehead Fluoromethyl Analogs of N-{2-[4-(2-Methoxyphenyl)Piperazin-1-yl]Ethyl}-N-(Pyridin-2-yl)Cyclohexanecarboxamide (WAY-100635) for the 5-HT(1A) Receptor Eur. J. Med. Chem. 2011, 46, 5728-5735 10.1016/j.ejmech.2011.06.023
Al Hussainy, R.; Verbeek, J.; van der Born, D.; Braker, A. H.; Leysen, J. E.; Knol, R. J.; Booij, J.; Herscheid, J. K. Design, Synthesis, Radiolabeling, and In Vitro and In Vivo Evaluation of Bridgehead Iodinated Analogues of N-{2-[4-(2-Methoxyphenyl)Piperazin-1-yl]Ethyl}-N-(Pyridin-2-yl)Cyclohexanecarboxamide (WAY-100635) as Potential SPECT Ligands for the 5-HT1A Receptor J. Med. Chem. 2011, 54, 3480-3491 10.1021/jm1009956
Childers, W. E., Jr.; Havran, L. M.; Asselin, M.; Bicksler, J. J.; Chong, D. C.; Grosu, G. T.; Shen, Z.; Abou-Gharbia, M. A.; Bach, A. C., 3rd; Harrison, B. L.; Kagan, N.; Kleintop, T.; Magolda, R.; Marathias, V.; Robichaud, A. J.; Sabb, A. L.; Zhang, M. Y.; Andree, T. H.; Aschmies, S. H.; Beyer, C.; Comery, T. A.; Day, M.; Grauer, S. M.; Hughes, Z. A.; Rosenzweig-Lipson, S.; Platt, B.; Pulicicchio, C.; Smith, D. E.; Sukoff-Rizzo, S. J.; Sullivan, K. M.; Adedoyin, A.; Huselton, C.; Hirst, W. D. The Synthesis and Biological Evaluation of Quinolyl-Piperazinyl Piperidines as Potent Serotonin 5-HT1A Antagonists J. Med. Chem. 2010, 53, 4066-4084 10.1021/jm1000908
Khatri, M.; Rai, S. K.; Alam, S.; Vij, A.; Tiwari, M. Synthesis and Pharmacological Evaluation of New Arylpiperazines N-[4-[4-(Aryl) Piperazine-1-yl]-Phenyl]-Amine Derivatives: Putative Role of 5-HT1A Receptors Bioorg. Med. Chem. 2009, 17, 1890-1897 10.1016/j.bmc.2009.01.043
Mangin, F.; Dilly, S.; Joly, B.; Scuvée-Moreau, J.; Evans, J.; Setola, V.; Roth, B. L.; Liégeois, J.-F. Moderate Chemical Modifications of WAY-100635 Improve the Selectivity for 5-HT1A versus D4 Receptors Bioorg. Med. Chem. Lett. 2012, 22, 4550-4554 10.1016/j.bmcl.2012.05.119
Marchais-Oberwinkler, S.; Nowicki, B.; Pike, V. W.; Halldin, C.; Sandell, J.; Chou, Y. H.; Gulyas, B.; Brennum, L. T.; Farde, L.; Wikstrom, H. V. N-oxide Analogs of WAY-100635: New High Affinity 5-HT(1A) Receptor Antagonists Bioorg. Med. Chem. 2005, 13, 883-893 10.1016/j.bmc.2004.10.033
SYBYL, version 8.0; Tripos Inc.: St. Louis, MO, 2008.
Consortium, T. U. O. a. f. d. a. t. U. P. R. N. A. R., 39, D214-D219 Ongoing and future developments at the Universal Protein Resource Nucleic Acids Res. 2011, 39, D214-D219 10.1093/nar/gkq1020
The Universal Protein Resource. http://www.uniprot.org/uniprot/P08908 (accessed July 1, 2016).
The Universal Protein Resource. http://www.uniprot.org/uniprot/P21917 (accessed July 1, 2016).
The Universal Protein Resource. http://www.uniprot.org/uniprot/P07700 (accessed July 1, 2016).
Shi, J.; Blundell, T. L.; Mizuguchi, K. FUGUE: Sequence-Structure Homology Recognition Using Environment-Specific Substitution Tables and Structure-Dependent Gap Penalties J. Mol. Biol. 2001, 310, 243-257 10.1006/jmbi.2001.4762
Baldwin, J. M.; Schertler, G. F.; Unger, V. M. An Alpha-Carbon Template for the Transmembrane Helices in the Rhodopsin Family of G-Protein-Coupled Receptors J. Mol. Biol. 1997, 272, 144-164 10.1006/jmbi.1997.1240
Dilly, S.; Liégeois, J.-F. Interaction of Clozapine and its Nitrenium Ion with Rat D2 Dopamine Receptors: In Vitro Binding and Computational Study J. Comput.-Aided Mol. Des. 2011, 25, 163-169 10.1007/s10822-010-9407-8
Warne, T.; Serrano-Vega, M. J.; Baker, J. G.; Moukhametzianov, R.; Edwards, P. C.; Henderson, R.; Leslie, A. G.; Tate, C. G.; Schertler, G. F. Structure of a Beta1-Adrenergic G-Protein-Coupled Receptor Nature 2008, 454, 486-491 10.1038/nature07101
Saunders, M. Stochastic Exploration of Molecular Mechanics Energy Surfaces. Hunting for the Global Minimum J. Am. Chem. Soc. 1987, 109, 3150-3152 10.1021/ja00244a051
Ballesteros, J. A.; Weinstein, H. [19] Integrated Methods for the Construction of Three-Dimensional Models and Computational Probing of Structure-Function Relations in G Protein-Coupled Receptors Methods Neurosci. 1995, 25, 366-428 10.1016/S1043-9471(05)80049-7
Bywater, R. P. Location and Nature of the Residues Important for Ligand Recognition in G-Protein Coupled Receptors J. Mol. Recognit. 2005, 18, 60-72 10.1002/jmr.685
Choudhary, M. S.; Craigo, S.; Roth, B. L. A Single Point Mutation (Phe340 → Leu340) of a Conserved Phenylalanine Abolishes 4-[125I]iodo-(2,5-dimethoxy)phenylisopropylamine and [3H]mesulergine but not [3H]ketanserin Binding to 5-Hydroxytryptamine2 Receptors Mol. Pharmacol. 1993, 43, 755-761
Salom, D.; Lodowski, D. T.; Stenkamp, R. E.; Le Trong, I.; Golczak, M.; Jastrzebska, B.; Harris, T.; Ballesteros, J. A.; Palczewski, K. Crystal Structure of a Photoactivated Deprotonated Intermediate of Rhodopsin Proc. Natl. Acad. Sci. U. S. A. 2006, 103, 16123-16128 10.1073/pnas.0608022103
Shapiro, D. A.; Kristiansen, K.; Kroeze, W. K.; Roth, B. L. Differential Modes of Agonist Binding to 5-Hydroxytryptamine(2A) Serotonin Receptors Revealed by Mutation and Molecular Modeling of Conserved Residues in Transmembrane Region 5 Mol. Pharmacol. 2000, 58, 877-886
Warne, T.; Moukhametzianov, R.; Baker, J. G.; Nehme, R.; Edwards, P. C.; Leslie, A. G.; Schertler, G. F.; Tate, C. G. The Structural Basis for Agonist and Partial Agonist Action on a Beta(1)-Adrenergic Receptor Nature 2011, 469, 241-244 10.1038/nature09746
Halgren, T. A. Merck Molecular Force Field. I. Basis, Form, Scope, Parameterization, and Performance of MMFF94 J. Comput. Chem. 1996, 17, 490-519 10.1002/(SICI)1096-987X(199604)17:6<490::AID-JCC1>3.3.CO;2-V
Dilly, S.; Scuvée-Moreau, J.; Wouters, J.; Liégeois, J.-F. The 5-HT1A agonism potential of substituted-piperazine-ethyl-amide derivatives is conserved in the hexyl homologues: molecular modeling and pharmacological evaluation J. Chem. Inf. Model. 2011, 51, 2961-2966 10.1021/ci200313r
Lovell, S. C.; Davis, I. W.; Arendall, W. B.; de Bakker, P. I. W.; Word, J. M.; Prisant, M. G.; Richardson, J. S.; Richardson, D. C. Structure Validation by Calpha Geometry: Phi, Psi and Cbeta Deviation Proteins: Struct., Funct., Genet. 2003, 50, 437-450 10.1002/prot.10286
Jones, G.; Willett, P.; Glen, R. C.; Leach, A. R.; Taylor, R. Development and Validation of a Genetic Algorithm for Flexible Docking J. Mol. Biol. 1997, 267, 727-748 10.1006/jmbi.1996.0897
Korb, O.; Stutzle, T.; Exner, T. E. Empirical Scoring Functions for Advanced Protein-Ligand Docking with PLANTS J. Chem. Inf. Model. 2009, 49, 84-96 10.1021/ci800298z
Graulich, A.; Léonard, M.; Résimont, M.; Huang, X. P.; Roth, B. L.; Liégeois, J.-F. Chemical Modifications on 4-Arylpiperazine-Ethyl Carboxamide Derivatives Differentially Modulate Affinity for 5-HT1A, D4.2, and α2A Receptors: Synthesis and In Vitro Radioligand Binding Studies Aust. J. Chem. 2010, 63, 56-67 10.1071/CH09353
Ho, B. Y.; Karschin, A.; Branchek, T.; Davidson, N.; Lester, H. A. The Role of Conserved Aspartate and Serine Residues in Ligand Binding and in Function of the 5-HT1A Receptor: a Site-Directed Mutation Study FEBS Lett. 1992, 312, 259-262 10.1016/0014-5793(92)80948-G
Nowak, M.; Kolaczkowski, M.; Pawlowski, M.; Bojarski, A. J. Homology Modeling of the Serotonin 5-HT1A Receptor using Automated Docking of Bioactive Compounds with Defined Geometry J. Med. Chem. 2006, 49, 205-214 10.1021/jm050826h
Kuipers, W.; Link, R.; Standaar, P. J.; Stoit, A. R.; Van Wijngaarden, I.; Leurs, R.; Ijzerman, A. P. Study of the Interaction between Aryloxypropanolamines and Asn386 in Helix VII of the Human 5-Hydroxytryptamine1A Receptor Mol. Pharmacol. 1997, 51, 889-896
Dilly, S.; Graulich, A.; Liégeois, J.-F. Molecular Modeling Study of 4-Phenylpiperazine and 4-Phenyl-1,2,3,6-Tetrahydropyridine Derivatives: a New Step Towards the Design of High-Affinity 5-HT1A Ligands Bioorg. Med. Chem. Lett. 2010, 20, 1118-1123 10.1016/j.bmcl.2009.12.027
Liégeois, J.-F.; Lespagnard, M.; Meneses Salas, E.; Mangin, F.; Scuvée-Moreau, J.; Dilly, S. Enhancing a CH-pi Interaction to Increase the Affinity for 5-HT1A Receptors ACS Med. Chem. Lett. 2014, 5, 358-362 10.1021/ml4004843
Burley, S. K.; Petsko, G. A. Aromatic-Aromatic Interaction: a Mechanism of Protein Structure Stabilization Science 1985, 229, 23-28 10.1126/science.3892686
Cummings, D. F.; Ericksen, S. S.; Goetz, A.; Schetz, J. A. Transmembrane Segment Five Serines of the D4 Dopamine Receptor Uniquely Influence the Interactions of Dopamine, Norepinephrine, and Ro10-4548 J. Pharmacol. Exp. Ther. 2010, 333, 682-695 10.1124/jpet.109.164962
